Purpose: The role of levetiracetam in different epileptic, nonepileptic, neurologic, and psychiatric disorders is discussed. Summary: Levetiracetam, an antiepileptic drug (AED), was first approved ...

Return on investment - most recent fiscal year 16.16 ...

Competition page helps you compare Cipla Ltd. with its sector peers on key parameters.

Cipla Fined Rs 1 Crore by GST Authority for Credit Claim Pharma company Cipla has been fined over Rs 1 crore by the GST authority for allegedly claiming inadmissible credit. The company plans to ...

Cipla is currently priced at Rs 1477.50, showing a modest increase of 0.38% today. The 5-day exponential moving average stands at Rs 1490.97, suggesting a stable trend in its recent performance. Cipla ...

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

Apart from the above, the company also develops medicines to treat a few other conditions. With a market capitalization exceeding Rs.517 billion (7.9 billion USD), Cipla is reported to be one of the ...

Pharma major Cipla Ltd on Friday (December 20, 2024) said a fine of over ₹1 crore has been imposed on the company by GST authority for alleged inadmissible credit claim. The company has received ...